BridgeBio Oncology Therapeutics, Inc. (BBOT)
NASDAQ: BBOT · Real-Time Price · USD
7.40
-0.29 (-3.77%)
Jun 26, 2026, 4:00 PM EDT - Market closed

BBOT Stock Forecast

Stock Price Forecast

The 9 analysts with 12-month price forecasts for BBOT stock have an average target of 25.11, with a low estimate of 18 and a high estimate of 41. The average target predicts an increase of 239.32% from the current stock price of 7.40.

Analyst Consensus: Strong Buy
Target Low Average Median High
Price $18 $25.11 $23 $41
Change +143.24% +239.32% +210.81% +454.05%

Analyst Ratings

The average analyst rating for BBOT stock from 10 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating Jan '26Feb '26Mar '26Apr '26May '26Jun '26
Strong Buy 566677
Buy 333333
Hold 000000
Sell 000000
Strong Sell 000000
Total 89991010

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
Mazahir Alimohamed
Oppenheimer
No rating
Oppenheimer
Buy
Maintains
$22
Buy Maintains $22 +197.30% Jun 22, 2026
Canaccord Genuity
Canaccord Genuity
Buy
Maintains
$23
Buy Maintains $23 +210.81% Jun 8, 2026
Piper Sandler
Piper Sandler
Buy
Maintains
$21
Buy Maintains $21 +183.78% Jun 1, 2026
Morgan Stanley
Morgan Stanley
Buy
Maintains
$18
Buy Maintains $18 +143.24% May 15, 2026
Wedbush
Wedbush
Buy
Maintains
$25
Buy Maintains $25 +237.84% May 14, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-2.23
from -4.30
EPS Next Year
-2.13
from -2.23
Fiscal Year FY 2023 FY 2024 FY 2025 FY 2026 FY 2027 FY 2028
Period Ending Dec 31, 2023 Dec 31, 2024 Dec 31, 2025 Dec 31, 2026 Dec 31, 2027 Dec 31, 2028
Revenue
------
Revenue Growth
------
EPS
-518.73-5,756.41-4.30-2.31-2.20-2.27
EPS Growth
------
Forward PE
------
No. Analysts ---887
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 202620272028
High n/a n/a
Avg n/a n/a
Low n/a n/a

Revenue Growth

Revenue Growth 20272028
High - -
Avg - -
Low - -

EPS Forecast

EPS 202620272028
High -1.72 -1.61
Avg -2.23 -2.13
Low -2.72 -2.37

EPS Growth

EPS Growth 202620272028
High - -
Avg - -
Low - -
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.